Factor XIII (FXIII) deficiency is a very rare severe autosomal bleeding disorder with a frequency of 1:2,000,000 in the general population and only a few patients have been genetically characterized so far. We report a phenotype-genotype characterization of 10 unrelated Iranian patients. Two FXIII (transglutaminase) activity assays showed no FXIII activity, except a conserved residual activity in patients receiving prophylactic substitution treatment. FXIII antigen concentrations measured by two immunoassays were comparable. Genotype characterization identified four novel mutations (2 missense and 2 small deletions)and two previously reported missense mutations in the FXIII A subunit gene (F13A). Molecular modeling was carried out to reveal the structural consequences of the missense mutations, that caused the replacement of an arginine residue involved in the formation of structurally important extensive hydrogen-bonded network. The replacements [c.320G>A (p.Arg77His) in the b-sandwich, c.868C>T (p.Arg260Cys), c.869G>A (p.Arg260His) and c.1236G>T (p.Arg382Ser) in the core domain] resulted in the loss or impairment of such Hbonded network. Energy decomposition analysis demonstrated that this situation leads to the instability and perhaps to the incorrect folding of the A subunit, that would explain the development of severe FXIII deficiency.

Phenotype-genotype characterization of 10 families with severe a subunit factor XIII deficiency / F. Peyvandi, L. Tagliabue, M. Menegatti, M. Karimi, I. Komáromi, E. Katona, L. Muszbek, P.M. Mannucci. - In: HUMAN MUTATION. - ISSN 1059-7794. - 23:1(2004 Jan), pp. 98-98. [10.1002/humu.9206]

Phenotype-genotype characterization of 10 families with severe a subunit factor XIII deficiency

F. Peyvandi
Primo
;
L. Tagliabue
Secondo
;
M. Menegatti;P.M. Mannucci
Ultimo
2004

Abstract

Factor XIII (FXIII) deficiency is a very rare severe autosomal bleeding disorder with a frequency of 1:2,000,000 in the general population and only a few patients have been genetically characterized so far. We report a phenotype-genotype characterization of 10 unrelated Iranian patients. Two FXIII (transglutaminase) activity assays showed no FXIII activity, except a conserved residual activity in patients receiving prophylactic substitution treatment. FXIII antigen concentrations measured by two immunoassays were comparable. Genotype characterization identified four novel mutations (2 missense and 2 small deletions)and two previously reported missense mutations in the FXIII A subunit gene (F13A). Molecular modeling was carried out to reveal the structural consequences of the missense mutations, that caused the replacement of an arginine residue involved in the formation of structurally important extensive hydrogen-bonded network. The replacements [c.320G>A (p.Arg77His) in the b-sandwich, c.868C>T (p.Arg260Cys), c.869G>A (p.Arg260His) and c.1236G>T (p.Arg382Ser) in the core domain] resulted in the loss or impairment of such Hbonded network. Energy decomposition analysis demonstrated that this situation leads to the instability and perhaps to the incorrect folding of the A subunit, that would explain the development of severe FXIII deficiency.
FXIII deficiency ; F13A ; transglutaminase ; molecular modeling
Settore MED/09 - Medicina Interna
gen-2004
Article (author)
File in questo prodotto:
File Dimensione Formato  
9206_ftp[1].pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 148.79 kB
Formato Adobe PDF
148.79 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/53744
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 44
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact